Holdings derived from the most recent reported transactions. Not adjusted for stock splits or share-class conversions.
| Issuer | Shares | Source | Last tx | Detail |
|---|---|---|---|---|
| Dianthus Therapeutics, Inc. /DE/ | 6,090 | reported | 21 May 2026 | tx 2+31,090 |
| Ra Pharmaceuticals, Inc. | 0 | reported | 02 Apr 2020 | tx 37+336,167−501,217 |
| Date | Type | Issuer | Qty | Price | Signals |
|---|---|---|---|---|---|
| 21 May 2026 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 6,090 | 0.00 USD | deriv |
| 22 May 2025 | GRANT_AWARD | Dianthus Therapeutics, Inc. /DE/ | 25,000 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 12,595 | 48.00 USD | |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 67,500 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 25,000 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 26,422 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 46,434 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 55,000 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 9,166 | 0.00 USD | deriv |
| 02 Apr 2020 | OTHER | Ra Pharmaceuticals, Inc. | 107,000 | 0.00 USD | deriv |
| 17 Dec 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 2.87 USD | |
| 17 Dec 2019 | SALE | Ra Pharmaceuticals, Inc. | 10,000 | 47.08 USD | |
| 17 Dec 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 14 Nov 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 2.87 USD | |
| 14 Nov 2019 | SALE | Ra Pharmaceuticals, Inc. | 10,000 | 46.68 USD | |
| 14 Nov 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 16 Oct 2019 | SALE | Ra Pharmaceuticals, Inc. | 10,000 | 46.87 USD | |
| 16 Oct 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 2.87 USD | |
| 16 Oct 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 12 Sept 2019 | SALE | Ra Pharmaceuticals, Inc. | 10,000 | 25.41 USD | |
| 12 Sept 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 2.87 USD | |
| 12 Sept 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |
| 23 Aug 2019 | SALE | Ra Pharmaceuticals, Inc. | 10,000 | 27.77 USD | |
| 23 Aug 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 2.87 USD | |
| 23 Aug 2019 | EXERCISE | Ra Pharmaceuticals, Inc. | 10,000 | 0.00 USD | deriv |